长短线釣鱼
2020-12-15
$Biocryst Pharmaceuticals(BCRX)$
涨了太快了。除了FDA刚批准的ORLADEYO 外,还有BCX9930 在Phase 1。前途看好,长期持有。
@Gerald17
。
@BrokeInvest:
$Biocryst Pharmaceuticals(BCRX)$BioCryst Pharma receives FDA approval for ORLADEYO https://bit.ly/2JJzxr1
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":394882208,"tweetId":"394882208","gmtCreate":1607998686304,"gmtModify":1703850508186,"author":{"id":3539680596515054,"idStr":"3539680596515054","authorId":3539680596515054,"authorIdStr":"3539680596515054","name":"长短线釣鱼","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":17,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BCRX\">$Biocryst Pharmaceuticals(BCRX)$</a>涨了太快了。除了FDA刚批准的ORLADEYO 外,还有BCX9930 在Phase 1。前途看好,长期持有。</p><p><a href=\"https://laohu8.com/U/3569240146863821\">@Gerald17</a>。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BCRX\">$Biocryst Pharmaceuticals(BCRX)$</a>涨了太快了。除了FDA刚批准的ORLADEYO 外,还有BCX9930 在Phase 1。前途看好,长期持有。</p><p><a href=\"https://laohu8.com/U/3569240146863821\">@Gerald17</a>。</p></body></html>","text":"$Biocryst Pharmaceuticals(BCRX)$涨了太快了。除了FDA刚批准的ORLADEYO 外,还有BCX9930 在Phase 1。前途看好,长期持有。 @Gerald17。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/394882208","repostId":396812089,"repostType":1,"repost":{"magic":2,"id":396812089,"tweetId":"396812089","gmtCreate":1607087277141,"gmtModify":1703846346321,"author":{"id":3569240146863821,"idStr":"3569240146863821","authorId":3569240146863821,"authorIdStr":"3569240146863821","name":"BrokeInvest","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":13,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BCRX\">$Biocryst Pharmaceuticals(BCRX)$</a>BioCryst Pharma receives FDA approval for ORLADEYO https://bit.ly/2JJzxr1</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/BCRX\">$Biocryst Pharmaceuticals(BCRX)$</a>BioCryst Pharma receives FDA approval for ORLADEYO https://bit.ly/2JJzxr1</p></body></html>","text":"$Biocryst Pharmaceuticals(BCRX)$BioCryst Pharma receives FDA approval for ORLADEYO https://bit.ly/2JJzxr1","highlighted":1,"essential":1,"paper":1,"link":"https://laohu8.com/post/396812089","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["BCRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":97,"xxTargetLangEnum":"ORIG"},"isVote":1,"tweetType":1,"viewCount":1569,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["BCRX"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":116,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/394882208"}
精彩评论